Newsletter sign-up

RESI Conference - San Francisco
Tuesday, 9 January 2018

We are looking forward to the RESI conference, where we will present our exciting growth opportunity to investors and other interested parties

Biologics Symposium - Copenhagen
Tuesday, 16 January 2018

As an active member of the biologics and regenerative medicine community, we are looking forward to the discussions at this meeting

Biotech & Money - London
Monday, 5 February 2018

Our CEO, Graeme Brookes, is an invited panel member for the CEO Panel discussion during the meeting

Bio-Europe Spring - Amsterdam
Monday, 12 February 2018

We look forward to discussing our unique investment opportunity at this key event

DK Bio - Boston
Tuesday, 10 April 2018

Once again, we look forward to being part of continuing to build and strengthen Danish-US life science connections

SAWC - Charlotte
Wednesday, 25 April 2018

We look forward to seeing friends and contacts at the SAWC

EWMA - Krakow
Wednesday, 9 May 2018

We will attend the whole conference and will also present at the ‘New Technologies in Wound Care’ Symposium in the Budapest Room at the congress centre on Thursday, May 10th 16.00 - 17.00

< Back to overview

Patent news – Patents granted in China and Canada

by Rasmus Lundquist

Reapplix ApS, developers of the unique LeucoPatch active wound therapy, have today announced that they have received notification of key patent grants in China and Canada. The Chinese patent office have granted Reapplix’s patent on the device used when producing a LeucoPatch, using the unique 3CP™ technology developed by the company (patent no. ZL201180045202.2). Furthermore, the Canadian patent office have also granted this patent (patent no. 2,811,777). Reapplix has strong patent protection across multiple key territories.

Top